Foghorn Therapeutics Inc.
FHTXAs of the close on Sep 25, 2026
Price
$3.50
Market cap
—
The cover-page share count does not match the latest report's share count
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Foghorn Therapeutics Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 25, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| UBS Group AG | 2026-03-31 | 75,835 | Not shown | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2026-03-31 | 60,100 | Not shown | SEC filing |
| Diversified Trust Co | 2026-03-31 | 10,852 | Not shown | SEC filing |
| Russell Investments Group, Ltd. | 2026-03-31 | 2,898 | Not shown | SEC filing |
| Wealth Preservation Advisors, LLC | 2026-03-31 | 13 | Not shown | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 1,871 | Not shown | SEC filing |
| Mirae Asset Global Investments Co., Ltd. | 2026-03-31 | 3,056 | Not shown | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 100 | Not shown | SEC filing |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2026-03-31 | 2,876 | Not shown | SEC filing |
| Jump Financial, LLC | 2026-03-31 | 13,740 | Not shown | SEC filing |
| STATE STREET CORP | 2026-03-31 | 679,787 | Not shown | SEC filing |
| RAYMOND JAMES FINANCIAL INC | 2026-03-31 | 2,602,382 | Not shown | SEC filing |
| GAMMA Investing LLC | 2026-03-31 | 864 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 9 | Not shown | SEC filing |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2026-03-31 | 5,295 | Not shown | SEC filing |
| Fiduciary Trust Co | 2026-03-31 | 10,879 | Not shown | SEC filing |
| ROYAL BANK OF CANADA | 2026-03-31 | 24 | Not shown | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 488 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 3,295 | Not shown | SEC filing |
| STATE OF WISCONSIN INVESTMENT BOARD | 2026-03-31 | 65,645 | Not shown | SEC filing |
- Each value is checked against Foghorn Therapeutics Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Ameritas Investment Partners, Inc.: 3,343 shares reported 2025-12-31; 3,343 shares reported 2026-03-31.
- GF FUND MANAGEMENT CO. LTD.: 1,111 shares reported 2025-12-31; 1,263 shares reported 2026-03-31.
- BlackRock, Inc.: 2,349,870 shares reported 2025-12-31; 2,364,866 shares reported 2026-03-31.
- CWM, LLC: 1,349 shares reported 2025-12-31; 3,345 shares reported 2026-03-31.
- True Wealth Design, LLC: 5 shares reported 2025-12-31; 20 shares reported 2026-03-31.
- Squarepoint Ops LLC: 141,580 shares reported 2025-12-31; 103,743 shares reported 2026-03-31.
- STRS OHIO: 8,600 shares reported 2025-12-31; 8,600 shares reported 2026-03-31.
- NORTHERN TRUST CORP: 262,430 shares reported 2025-12-31; 275,875 shares reported 2026-03-31.
- ALLIANCEBERNSTEIN L.P.: 26,660 shares reported 2025-12-31; 26,660 shares reported 2026-03-31.
- PANAGORA ASSET MANAGEMENT INC: 89,295 shares reported 2025-12-31; 115,063 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 795,040 shares reported 2025-12-31; 848,172 shares reported 2026-03-31.
- Euclidean Capital LLC: 1,573,761 shares reported 2025-12-31; 1,573,761 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
82 filers have only one report here.
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2024-09-23 | Costa Carlos · Chief People Officer | Common Stock | S — Open market or private sale | −857 | 10.17 | SEC filing |
| 2024-09-20 | Costa Carlos · Chief People Officer | Common Stock | S — Open market or private sale | −35,756 | 10.04 | SEC filing |
| 2024-09-18 | Costa Carlos · Chief People Officer | Common Stock | S — Open market or private sale | −11,574 | 10.05 | SEC filing |
| 2024-09-17 | Costa Carlos · Chief People Officer | Common Stock | S — Open market or private sale | −10,272 | 10.04 | SEC filing |
| 2024-09-16 | Costa Carlos · Chief People Officer | Common Stock | S — Open market or private sale | −400 | 10.00 | SEC filing |
| 2024-09-09 | Bellon Steven F. · Chief Scientific Officer | Common Stock | S — Open market or private sale | −20,000 | 9.50 | SEC filing |
| 2024-05-22 | AFEYAN NOUBAR · 10% owner | Pre-Funded Warrants to purchase Common Stock | P — Open market or private purchase | +1,814,914 | 5.51 | SEC filing |
| 2024-05-22 | AFEYAN NOUBAR · 10% owner | Pre-Funded Warrants to purchase Common Stock | P — Open market or private purchase | +1,814,915 | 5.51 | SEC filing |
Showing 8 of 13 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-24 | GILL SIMBA · Director | Stock Options (Right to buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-24 | SMITH IAN F · Director | Stock Options (Right to buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-24 | Lynch Thomas J. Jr. · Director | Stock Options (Right to buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-24 | Mendelsohn Michael · Director | Stock Options (Right to buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-24 | Gallagher Neil · Director | Stock Options (Right to buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-24 | PARSHALL B LYNNE · Director | Stock Options (Right to buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-24 | Biller Scott · Director | Stock Options (Right to buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-24 | Duty Stuart · Director | Stock Options (Right to buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
Showing 8 of 30 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-02-17 | GOTTSCHALK ADRIAN · Chief Executive Officer | Common Stock | J — Other acquisition or disposition | −184,939 | SEC filing |
| 2023-02-17 | GOTTSCHALK ADRIAN · Chief Executive Officer | Common Stock | J — Other acquisition or disposition | +184,939 | SEC filing |
| 2022-10-25 | GOTTSCHALK ADRIAN · Chief Executive Officer | Common Stock | J — Other acquisition or disposition | −4,371 | SEC filing |
| 2022-10-25 | GOTTSCHALK ADRIAN · Chief Executive Officer | Common Stock | J — Other acquisition or disposition | +4,371 | SEC filing |
Showing 4 of 4 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.